SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #897CAS 2区Hybrid

Biodrugs

Abbreviation (ISO):BIODRUGS
Country: New Zealand•WoS SCIE Quartile: Q1•Scopus SJR: 2.628•SCImago Rank: #897•Identifier (ISSN):1173-8804(Print)/1179-190X(Online)•Articles / Year: 47•Estimated Publication Fee (APC): $3,776 USD
Clarivate IF (2026)Q1
8.5
↑ +1.6

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
60

60 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate5.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
47articles/year
57.31% Gold OA•58.18% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 8.5)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 8.5)
🔵 Computed
20253.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.9)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.4)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 6.8)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 7.744)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.807)
🔵 Computed
20203.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.313)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.903)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 3.825)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

An essential resource for R&D professionals and clinicians with an interest in biologic therapies. BioDrugs covers the development and therapeutic application of biotechnology-based pharmaceuticals and diagnostic products for the treatment of human disease. BioDrugs offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist patients, caregivers and others in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Topics Covered (Recognized by AI)
Medicine97.5%Biology95.4%Internal medicine86%Genetics77.8%Immunology62.7%Pathology55.7%Chemistry51.6%Biochemistry47.3%Pharmacology41.8%Surgery33.7%Psychology30.9%Endocrinology27.7%Psychiatry27.2%Bioinformatics25.8%Disease25.4%Immune system23.4%Antibody23.3%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #897Scopus Q1SCImago Profile
Scopus Coverage:1996-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
2.628

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
90

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
8.60

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,776 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,474
3-Year Documents169
Citable Documents165

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate45.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

BiotechnologyQ1
Medicine (miscellaneous)Q1
PharmacologyQ1
Pharmacology (medical)Q1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Springer International Publishing
Publication Language
English
Frequency
Bimonthly
Founding Year
1994
Editorial Address
ADIS INT LTD, 41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND, NEW ZEALAND, 1311
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
IMMUNOLOGY
JCRSCIE
19/183Q1
ONCOLOGY
JCRSCIE
40/333Q1
PHARMACOLOGY & PHARMACY
JCRSCIE
19/356Q1
IMMUNOLOGY
JCISCIE
31/183Q1
ONCOLOGY
JCISCIE
55/333Q1
PHARMACOLOGY & PHARMACY
JCISCIE
44/356Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—5223
20256.961429
20245.458859
20236.8661,805
20227.744601,824
20215.807511,526
20205.313622,281
20194.903713,311
20183.825652,797
2017—483,602
2016—521,866
2015—351,655
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Biodrugs

WoS Q1
2479201820192020202120222023202420256.90
Annual Impact Factor Metric
2025:6.9

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 5536b5ed-a821-4ea7-bed2-7d18f879ff33
Database Updated: 2026-10-01